IP Library Granted Patent US 10,286,176
Granted Patent B2
US 10,286,176 · App. 15/907,241 · Granted May 14, 2019

Systems and methods for generating nitric oxide

Inventors: David G. Zapol (San Francisco, CA); Gregory W. Hall (Belmont, MA); Wolfgang Scholz (Beverly, MA)
Assignee: Third Pole, Inc.
A61M16/12A61K33/00A61M16/0057A61M16/0093A61M16/022A61M16/024A61M16/04A61M16/0666A61M16/101A61M16/107A61M16/202C01B21/32A61M2202/0275A61M2202/0283A61M2205/05A61M2205/054A61M2205/125A61M2205/3584A61M2205/502A61M2205/80A61M2205/8206A61M2209/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,286,176
App. No.
15/907,241
Granted
May 14, 2019
Kind
B2
Abstract

Systems and methods for nitric oxide generation are provided. In an embodiment, an NO generation system can include a controller and disposable cartridge that can provide nitric oxide to two different treatments simultaneously. The disposable cartridge has multiple purposes including preparing incoming gases for exposure to the NO generation process, scrubbing exhaust gases for unwanted materials, characterizing the patient inspiratory flow, and removing moisture from sample gases collected. Plasma generation can be done within the cartridge or within the controller. The system has the capability of calibrating NO and NO 2 gas analysis sensors without the use of a calibration gas.

Claims (39)

1. A nitric oxide generation system, comprising:

one or more plasma chambers each including one or more electrodes configured to generate a product gas containing nitric oxide using a flow of a reactant gas through the one or more plasma chambers;

a controller configured to regulate the amount of nitric oxide generated in the product gas by the one or more electrodes in the one or more plasma chambers using one or more parameters as input to a control algorithm, at least one of the one or more parameters being related to the flow rate of the reactant gas into the one or more plasma chambers;

a reactant gas source that is configured to provide instantaneous high pressure reactant gas to the one or more plasma chambers;

a flow controller positioned between the reactant gas source and the one or more plasma chambers and configured to provide a controlled continuous variable flow of the reactant gas from the reactant gas source based on a measurement associated with a medical gas into which the product gas flows; and

one or more scavenger paths configured to remove NO 2 from the product gas generated by the one or more plasma chambers,

wherein the concentration of NO in a combination of the product gas and the medical gas is a target value, and

wherein the measurement associated with the medical gas is the flow rate of the medical gas such that the air flow of the reactant gas through the one or more plasma chambers is proportional to the flow rate of the medical gas.

2. The nitric oxide generation system of claim 1 , wherein the reactant gas source is in the form of a reservoir.

3. The nitric oxide generation system of claim 1 , wherein the reactant gas source is in the form of a pump.

4. The nitric oxide generation system of claim 1 , wherein the flow controller is selected from the group consisting of one or more proportional valves, one or more digital valves, and a combination of at least one proportional valve and at least one digital valves.

5. The nitric oxide generation system of claim 1 , further comprising one or more filters positioned to receive NO-enriched air from the one or more scavenger paths and configured to filter the NO-enriched air.

6. The nitric oxide generation system of claim 1 , further comprising a digital signal processor that generates a continuous, customizable control AC waveform as an input to a high voltage circuit.

7. The nitric oxide generation system of claim 6 , wherein the digital signal processor is configured to control the shape of the AC waveform by controlling its frequency and duty cycle.

8. A nitric oxide generation system, comprising:

one or more plasma chambers each including one or more electrodes configured to generate a product gas containing nitric oxide using a flow of a reactant gas through the one or more plasma chambers;

a controller configured to regulate the amount of nitric oxide generated in the product gas by the one or more electrodes in the one or more plasma chambers using one or more parameters as input to a control algorithm, at least one of the one or more parameters being related to the flow rate of the reactant gas into the one or more plasma chambers;

a reactant gas source that is configured to provide instantaneous high pressure reactant gas to the one or more plasma chambers; and

a flow controller positioned between the reactant gas source and the one or more plasma chambers and configured to provide a controlled continuous variable flow of the reactant gas from the reactant gas source based on a measurement associated with a medical gas into which the product gas flows,

wherein the concentration of NO in a combination of the product gas and the medical gas is a target value, and

wherein the measurement associated with the medical gas is the flow rate of the medical gas such that the air flow of the reactant gas through the one or more plasma chambers is proportional to the flow rate of the medical gas.

9. The nitric oxide generation system of claim 8 , further comprising one or more scavenger paths configured to remove NO 2 from the product gas generated by the one or more plasma chambers.

10. The nitric oxide generation system of claim 8 , wherein the reactant gas source is in the form of a reservoir.

11. The nitric oxide generation system of claim 8 , wherein the reactant gas source is in the form of a pump.

12. A nitric oxide generation system, comprising:

one or more plasma chambers each including one or more electrodes configured to generate a product gas containing nitric oxide using a flow of a reactant gas through the one or more plasma chambers;

a controller configured to control the amount of nitric oxide generated in the product gas by the one or more electrodes in the one or more plasma chambers based on a control algorithm with one or more input parameters by varying at least one or more of the flow rate of the reactant gas into the one or more plasma chambers and a plasma power in the one or more plasma chambers;

a reactant gas source that is configured to provide instantaneous high pressure reactant gas to the one or more plasma chambers; and

a flow controller positioned between the reactant gas source and the one or more plasma chambers and configured to provide a controlled continuous variable flow of the reactant gas from the reactant gas source based on a measurement associated with a medical gas into which the product gas flows;

wherein the concentration of NO in a combination of the product gas and the medical gas is a target value, and

wherein the measurement associated with the medical gas is the flow rate of the medical gas such that the air flow of the reactant gas through the one or more plasma chambers is proportional to the flow rate of the medical gas.

13. The nitric oxide generation system of claim 12 , wherein the control algorithm input parameters are selected from the group consisting of concomitant treatment parameters, patient parameters, ambient environment parameters, device parameters, and NO treatment parameters.

14. The nitric oxide generation system of claim 13 , wherein the concomitant treatment parameters include flow, pressure, gas temperature, or gas humidity information relating to one or more devices being used in conjunction with the NO generation system.

15. The nitric oxide generation system of claim 13 , wherein the patient parameters include inspiratory flow, SpO 2 , breath detection, tidal volume, minute volume, or expiratory NO 2 .

16. The nitric oxide generation system of claim 13 , wherein the ambient environment parameters include ambient temperature, ambient pressure, ambient humidity, ambient NO, or ambient NO 2 .

17. The nitric oxide generation system of claim 13 , wherein the device parameters include plasma chamber pressure, plasma chamber flow, plasma chamber temperature, plasma chamber humidity, electrode temperature, electrode type, or electrode gap.

18. The nitric oxide generation system of claim 13 , wherein the NO treatment parameters include target NO concentration, indicated NO concentration, or indicated NO 2 concentration.

19. The nitric oxide generation system of claim 12 , further comprising one or more scavenger paths configured to remove NO 2 from the product gas generated by the one or more plasma chambers.

20. The nitric oxide generation system of claim 12 , wherein the reactant gas source is in the form of a reservoir.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 19, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND L.P.
To: THIRD POLE, INC.
Reel/Frame 066825/0518 →
SECURITY INTEREST Recorded Mar 18, 2024
From: THIRD POLE, INC.
To: AMERICAN MONEY MANAGEMENT CORPORATION
Reel/Frame 066812/0657 →
SECURITY AGREEMENT Recorded Apr 12, 2021
From: THIRD POLE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
Reel/Frame 055986/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2018
From: ZAPOL, DAVID G.; HALL, GREGORY W.; SCHOLZ, WOLFGANG
To: THIRD POLE, INC.
Reel/Frame 045131/0362 →
Continuity (7)
Provisional Application 62614492 · Jan 7, 2018
Provisional Application 62574173 · Oct 18, 2017
Provisional Application 62553572 · Sep 1, 2017
Provisional Application 62509394 · May 22, 2017
Provisional Application 62463943 · Feb 27, 2017
Provisional Application 62463956 · Feb 27, 2017
Related Publication 20180243527A1 · Aug 30, 2018
Cited By (5)
US 12,509,349 US 12,522,501 US 12,569,628 US 12,576,234 US 12,606,436